Aaron Bloomer - 15 Apr 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
EVP, Chief Financial Officer
Signature
/s/ Aaron Bloomer by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
15 Apr 2025
Net transactions value
-$479,537
Form type
4
Filing time
17 Apr 2025, 16:30:10 UTC
Previous filing
26 Feb 2025
Next filing
30 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +11,556 $0.000000 11,556 15 Apr 2025 Direct F1
transaction EXAS Common Stock Tax liability $226,560 -5,120 -44% $44.25 6,436 15 Apr 2025 Direct F2
transaction EXAS Common Stock Options Exercise $0 +12,904 +200% $0.000000 19,340 15 Apr 2025 Direct F1
transaction EXAS Common Stock Tax liability $252,977 -5,717 -30% $44.25 13,623 15 Apr 2025 Direct F2, F3
holding EXAS Common Stock 212 15 Apr 2025 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -11,566 -100% $0.000000 0 15 Apr 2025 Common Stock 11,566 Direct F4, F5
transaction EXAS Restricted Stock Units Options Exercise $0 -12,904 -25% $0.000000 38,715 15 Apr 2025 Common Stock 12,904 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 13,835 shares, Mr. Bloomer also holds, in the aggregate, an additional 67,494 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 Represents a restricted stock unit award granted on April 15, 2024 that vested in full on the one-year anniversary of the grant date.
F6 Represents a restricted stock unit award granted on April 15, 2024 that vests in four equal annual installments from the grant date.